Typical project outcomes:


Our technology platform:

  • L2L: Leap-to-Lead™ Overview

  • CFL: A proprietary next generation 3D fragment library

  • Syntheverse™: Improved access to currently synthesizable compounds


BioBlocks chemists are often inventors on our clients' patents: